Akebia Therapeutics, Inc.
NASDAQ:AKBABiotechnology
Healthcare
$0.41 +0.49%
+$0.01 today
- Market cap
- $113.54M
- Beta
- 0.25
- P/E (TTM)
- -13.3
- EPS (TTM)
- -$0.08
52W Low $0.82High $4.08
Volume 7.09M
Average 4.03M
Price history
Akebia Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-74.28%
Period high
$1.70
Period low
$0.40
Latest
$0.41
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Oct 23, 2026 | Oct 23, 2026 | |
| 8-K | Oct 14, 2026 | Oct 14, 2026 | |
| 4 | Aug 10, 2026 | Aug 10, 2026 | |
| 10-Q | Aug 5, 2026 | Aug 5, 2026 | |
| S-8 | Aug 5, 2026 | Aug 5, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Jul 1, 2026 | Jul 1, 2026 | |
| 8-K | Jun 30, 2026 | Jun 30, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 | |
| 8-K | Jun 22, 2026 | Jun 22, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 |
Competitors
Who does Akebia Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about AKBA's filings, answered from its disclosures.
What is the latest AKBA filing?
The latest filing shown is 8-K dated Nov 5, 2026.
How many recent filings does AKBA have?
Intrinsic Alpha currently shows 20 recent filings for AKBA.
Continue the stock analysis
Jump to another research area for this company.